Stentorian Ventures refuses to allow the impact of cancer to be ignored and unheard.
About the Firm
Innovation Beyond Cancer Research
As a venture capital firm, we integrate impact investing with the deployment of technical expertise to drive innovation in cancer research from bench to bedside. Our scientific and medical expertise brings highly technical investments within the range of our partners.
Our focus areas
- Biotech
- Medtech
- Digital Health
- Healthcare IT
- Machine Learning / AI
Meet Our Team
Robyn Leary, PhD
Managing Partner
